TXA2 attenuates allergic lung inflammation through regulation of Th2, Th9, and Treg differentiation
In lung, thromboxane A2 (TXA2) activates the TP receptor to induce proinflammatory and bronchoconstrictor effects. Thus, TP receptor antagonists and TXA2 synthase inhibitors have been tested as potential asthma therapeutics in humans. Th9 cells play key roles in asthma and regulate the lung immune r...
Bewaard in:
| Hoofdauteurs: | , , , , , , , , , , , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
American Society for Clinical Investigation
2024-05-01
|
| Reeks: | The Journal of Clinical Investigation |
| Onderwerpen: | |
| Online toegang: | https://doi.org/10.1172/JCI165689 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|
